Pages that link to "Q36986295"
Jump to navigation
Jump to search
The following pages link to Evaluating the Prostate Cancer Prevention Trial High Grade Prostate Cancer Risk Calculator in 10 international biopsy cohorts: results from the Prostate Biopsy Collaborative Group. (Q36986295):
Displaying 17 items.
- Evaluation of Prostate Cancer Risk Calculators for Shared Decision Making Across Diverse Urology Practices in Michigan. (Q30399140) (← links)
- External Evaluation of a Novel Prostate Cancer Risk Calculator (ProstateCheck) Based on Data from the Swiss Arm of the ERSPC. (Q31096808) (← links)
- Importance of prostate volume in the European Randomised Study of Screening for Prostate Cancer (ERSPC) risk calculators: results from the prostate biopsy collaborative group. (Q35875135) (← links)
- Improving patient prostate cancer risk assessment: Moving from static, globally-applied to dynamic, practice-specific risk calculators (Q38630811) (← links)
- The impact of prostate volume, number of biopsy cores and American Urological Association symptom score on the sensitivity of cancer detection using the Prostate Cancer Prevention Trial risk calculator (Q37001612) (← links)
- Evolution and immediate future of US screening guidelines (Q38203982) (← links)
- Predicting Prostate Biopsy Results Using a Panel of Plasma and Urine Biomarkers Combined in a Scoring System (Q38325768) (← links)
- Risk stratification of prostate cancer: integrating multiparametric MRI, nomograms and biomarkers (Q38843182) (← links)
- The prostate cancer prevention trial risk calculator 2.0 performs equally for standard biopsy and MRI/US fusion-guided biopsy. (Q38950693) (← links)
- Multiparametric magnetic resonance imaging outperforms the Prostate Cancer Prevention Trial risk calculator in predicting clinically significant prostate cancer (Q40199490) (← links)
- Development and external multicenter validation of Chinese Prostate Cancer Consortium prostate cancer risk calculator for initial prostate biopsy (Q40374504) (← links)
- Practice patterns of urologists in managing Korean men aged 40 years or younger with high serum prostate-specific antigen levels. (Q42219662) (← links)
- A Contemporary Prostate Biopsy Risk Calculator Based on Multiple Heterogeneous Cohorts (Q59574937) (← links)
- Adaptation and external validation of the European randomised study of screening for prostate cancer risk calculator for the Chinese population (Q88870987) (← links)
- Multi-cohort modeling strategies for scalable globally accessible prostate cancer risk tools (Q90727230) (← links)
- Engaging African American Men as Citizen Scientists to Validate a Prostate Cancer Biomarker: Work-in-Progress (Q92397343) (← links)
- Editorial Comment (Q95514933) (← links)